Skip to content

13F-HR filed by Tri Locum Partners LP

Tri Locum Partners LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 34 holding rows worth $403,245,000.

Accession
0001826434-21-000004
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 35 entries on the cover page, a total value of $403,245,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $403,245,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WALGREENS BOOTS ALLIANCE INC931427108COM770,000$42,273,000thousands by filing dateput
WALGREENS BOOTS ALLIANCE INC931427108COM770,000$42,273,000thousands by filing datecall
REGENERON PHARMACEUTICALS COM75886F107Stock64,705$30,615,000thousands by filing date
Medtronic PlcG5960L103COM239,644$28,309,000thousands by filing date
Johnson & Johnson478160104COM168,634$27,715,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS293,426$27,007,000thousands by filing date
BAXTER INTL INC071813109COM314,136$26,494,000thousands by filing date
Bristol-Myers Squibb Company110122108COM390,992$24,683,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM399,842$21,951,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock110,382$18,143,000thousands by filing date
HUMANA INC COM444859102Stock35,693$14,964,000thousands by filing date
NUANCE COMMUNICATIONS INC67020Y100COM333,482$14,553,000thousands by filing date
Eli Lilly and Company532457108COM48,299$9,023,000thousands by filing date
9 METERS BIOPHARMA INC654405109COM6,644,337$7,774,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock148,620$7,163,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM257,086$6,659,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO321,101$6,608,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock578,930$6,218,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock164,199$4,138,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW196,672$4,051,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM180,261$4,031,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM1,210,863$3,911,000thousands by filing date
CASI PHARMACEUTICALS INC14757U109COM1,500,000$3,600,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM142,911$3,467,000thousands by filing date
LIFESCI ACQUISITION II CORP53229E103COM300,000$3,042,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM140,000$2,502,000thousands by filing dateput
AERIE PHARMACEUTICALS INC00771V108COM140,000$2,502,000thousands by filing datecall
CYCLACEL PHARMACE 6percent PFDCONV23254L603Stock293,419$2,086,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM380,237$1,460,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO160,256$1,449,000thousands by filing date
IMMATICS N.VN44445109SHS121,743$1,365,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM68,472$1,224,000thousands by filing date
EVOLUS INC30052C107COM81,025$1,053,000thousands by filing date
AMNEAL PHARMACEUTICALS INC03168L105COM STK CL A139,470$939,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001826434-21-000004this filing2021-05-17acceptance time not in the bulk data set